Cryo-Cell International Inc CCEL:NYSE American

Last Price$4.09Cboe Previous Close - Real-Time Last Sale as of 12:15PM ET 1/27/23
Cboe Real-Time Quotes
Today's Change+0.001(0.03%)
Bid (Size)$3.96 (100)
Ask (Size)$4.12 (100)
Day Low / High$4.12 - 4.46

View Other Transportation IndustryPeer Comparison as of 01/27/2023


Cryo-Cell International Inc ( NYSE MKT LLC )

Price: $4.09
Change: +0.001 (0.03%)
Volume: 256.00
12:15PM ET 1/27/2023

UnderSea Recovery Corp ( OTC )

Price: $0.0002
Change: 0.00 (0.00%)
Volume: 100.0 K
10:31AM ET 12/21/2022

Yangtze River Port and Logistics Ltd ( OTC )

Price: $0.0002
Change: 0.00 (0.00%)
Volume: 2.1 K
12:11PM ET 1/26/2023

N/A ( N/A )

Price: N/A
Change: N/A N/A
Volume: N/A

SEACOR Marine Holdings Inc ( NYSE )

Price: $10.15
Change: +0.02 (0.20%)
Volume: 7.9 K
11:02AM ET 1/31/2023

Read more news Recent News

Insider Buy: Cryo Cell International
5:30PM ET 11/10/2022 MT Newswires

David Portnoy, 10% Owner, Director, Chairman, Co-CEO, on November 08, 2022, executed a purchase for 23,850 shares in Cryo Cell International (CCEL) for...

--Maxim Starts Cryo-Cell International at Buy With $12 Price Target
9:01AM ET 8/29/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Cryo-Cell International to Transfer Listing to NYSE American Stock Exchange
5:08PM ET 8/17/2022 MT Newswires

Cryo-Cell International (CCEL) said Wednesday it will transfer its listing from the Nasdaq Capital Market to the NYSE American stock exchange on Aug. 30....

View all Commentary and Analysis

Cryo-Cell International: A Stable Business Paired With An Upcoming Catalyst
5:16PM ET 2/11/2022 Seeking Alpha

Company Profile

Business DescriptionCryo-Cell International, Inc. is cord blood bank, which engages in providing stem cell cryopreservation services and advancing regenerative medicine. It operates through the following segments: Cellular Processing and Cryogenic Storage, and Prepacyte CB. The Cellular Processing and Cryogenic Storage segment focuses on the collection and preservation of umbilical cord blood and tissue stem cells for family use. The Prepacyte CB segment refers to the processing technology used to process umbilical cord blood stem cells. The company was founded in 1989 and is headquartered in Oldsmar, FL. View company web site for more details
Address700 Brooker Creek Boulevard
Oldsmar, Florida 34677
Number of Employees92
Recent SEC Filing01/17/20234
Chairman & Co-Chief Executive OfficerDavid I. Portnoy
Co-Chief Executive Officer & DirectorMark L. Portnoy
Chief Financial Officer & Vice President-FinanceJill M. Taymans
Chief Information OfficerOleg Mikulinsky

Company Highlights

Price Open$4.14
Previous Close$4.09
52 Week Range$4.00 - 9.82
Market Capitalization$34.8 M
Shares Outstanding8.5 M
IndustryOther Transportation
Next Earnings Announcement02/28/2023

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / Earnings26.87
Earnings per Share$0.16
Beta vs. S&P 500N/A
Revenue$29.2 M
Net Profit Margin4.34%
Return on Equity49.59%

Analyst Ratings as of 08/26/2022

Consensus RecommendationConsensus Icon
Powered by Factset